Style de citation APA (7e éd.)

Tsubata, Y., Tanino, R., & Isobe, T. (2021). Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG.

Style de citation Chicago (17e éd.)

Tsubata, Yukari, Ryosuke Tanino, et Takeshi Isobe. Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG, 2021.

Style de citation MLA (8e éd.)

Tsubata, Yukari, et al. Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance. MDPI AG, 2021.